Company news

Hikma Pharmaceuticals PLC news in 2018

Hikma Pharmaceuticals PLC's news releases, calls and decks from 2018, newest first.

View company

Hikma launches Clobazam

December 10, 2018

Hikma announces injectable licensing agreement

November 27, 2018

Hikma launches Triazolam Tablets

November 19, 2018

Hikma announces agreement with Vectura

November 8, 2018

Hikma enters licensing partnership with Perrigo

July 9, 2018

Hikma appoints Chief Transformation Officer

June 4, 2018

Hikma launches Methylergonovine Maleate Tablets

May 30, 2018

AGM Results

May 18, 2018

Hikma launches Methotrexate Injection

May 3, 2018

Hikma expands licensing agreement with Rovi

April 24, 2018

Hikma launches Dexrazoxane for Injection

April 20, 2018

Hikma launch-Palonosetron Hydrochloride Injection

March 29, 2018

Hikma has launched Ritonavir Tablets USP

March 20, 2018

Update status on ANDA for generic Advair Diskus®

March 12, 2018

Sigurdur Olafsson appointed CEO of Hikma

February 20, 2018

Hikma Appoints Dr. Surendera Tyagi

January 15, 2018

Decks in 2018